Instinct Bio Technical Company Holdings Inc. Ordinary Shares (BIOT) - Total Liabilities
Based on the latest financial reports, Instinct Bio Technical Company Holdings Inc. Ordinary Shares (BIOT) has total liabilities worth $912.54K USD as of May 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BIOT cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Instinct Bio Technical Company Holdings Inc. Ordinary Shares - Total Liabilities Trend (2023–2024)
This chart illustrates how Instinct Bio Technical Company Holdings Inc. Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Instinct Bio Technical Company Holdings generate to measure how efficiently the company converts operating cash flow to free cash.
Instinct Bio Technical Company Holdings Inc. Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Instinct Bio Technical Company Holdings Inc. Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avillion Bhd
KLSE:8885
|
Malaysia | RM136.66 Million |
|
Zenta Group Company Limited
NASDAQ:ZTG
|
USA | $407.14K |
|
SL Private Equity
LSE:SLPE
|
UK | GBX142.36 Million |
|
High Arctic Energy Services Inc.
TO:HWO
|
Canada | CA$7.84 Million |
|
In8bio Inc
NASDAQ:INAB
|
USA | $3.38 Million |
|
Perfect Moment Ltd.
NYSE MKT:PMNT
|
USA | $12.74 Million |
|
VL E-Governance & IT Solutions Limited
NSE:VLEGOV
|
India | Rs-456.97 Million |
|
Crescita Therapeutics Inc
TO:CTX
|
Canada | CA$4.75 Million |
Liability Composition Analysis (2023–2024)
This chart breaks down Instinct Bio Technical Company Holdings Inc. Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Instinct Bio Technical Company Holdings total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Instinct Bio Technical Company Holdings Inc. Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Instinct Bio Technical Company Holdings Inc. Ordinary Shares (2023–2024)
The table below shows the annual total liabilities of Instinct Bio Technical Company Holdings Inc. Ordinary Shares from 2023 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-11-30 | $767.89K | -30.80% |
| 2023-11-30 | $1.11 Million | -- |
About Instinct Bio Technical Company Holdings Inc. Ordinary Shares
Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.